News Daily News Telemedicine May Adversely Impact Care Quality for HF Patients Caitlin E. Cox January 26, 2026
News Daily News Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke Todd Neale January 07, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT Todd Neale December 15, 2025
News Daily News Getting Ready for a Heart Failure Polypill, Well Before the Data Are In Todd Neale October 16, 2025
News Daily News HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease Todd Neale October 02, 2025
News Daily News LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke Todd Neale September 30, 2025
News Daily News HF Risks Stick Around Even When Ejection Fraction Improves Todd Neale August 01, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients Michael O'Riordan June 16, 2025
News Daily News Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI L.A. McKeown June 05, 2025
News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Daily News Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM L.A. McKeown April 15, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Daily News REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF Michael O'Riordan March 11, 2025
News Daily News Sotagliflozin Reduces Ischemic Risk in SCORED Analysis Yael L. Maxwell February 25, 2025
News Daily News Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time Michael O'Riordan February 13, 2025
News Daily News Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit Michael O'Riordan January 13, 2025